Author: Romagosa, Anna; Allerson, Matt; Gramer, Marie; Joo, Han Soo; Deen, John; Detmer, Susan; Torremorell, Montserrat
Title: Vaccination of influenza a virus decreases transmission rates in pigs Document date: 2011_12_20
ID: 0q8fedqf_26
Snippet: Blood samples were collected using venipucture of the jugular vein. After collection serum was separated and stored at -20°C. Sera were subsequently analyzed for the detection of influenza virus antibodies by HI and influenza A Multiscreen ELISA. HI tests were performed following standard procedures [40] . Samples were tested by HI against the challenge strain (IA04), the licensed commercial vaccine isolates γ and δ (A/Sw/IA/110600/ 00 and A/S.....
Document: Blood samples were collected using venipucture of the jugular vein. After collection serum was separated and stored at -20°C. Sera were subsequently analyzed for the detection of influenza virus antibodies by HI and influenza A Multiscreen ELISA. HI tests were performed following standard procedures [40] . Samples were tested by HI against the challenge strain (IA04), the licensed commercial vaccine isolates γ and δ (A/Sw/IA/110600/ 00 and A/Sw/NC/031/2005, respectively), and H3N2 (A/ Sw/MO/069/2005 H3N2) at arrival, thirteen days after the second vaccine, and at necropsy. Additionally, all sera were tested using the Influenza A Multiscreen ELISA following manufacturer's protocols. The Influenza A Multiscreen ELISA measures antibodies directed against the nucleoprotein (NP) of influenza A viruses.
Search related documents:
Co phrase search for related documents- blood sample and influenza virus: 1, 2, 3, 4, 5
- blood sample and jugular vein: 1
- blood sample and measure antibody: 1, 2, 3, 4, 5, 6
- blood sample and second vaccine: 1, 2, 3
- challenge strain and commercial vaccine: 1, 2, 3, 4, 5, 6, 7
- challenge strain and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- challenge strain and influenza virus antibody: 1
- challenge strain and licensed commercial vaccine: 1
- challenge strain and measure antibody: 1, 2
- challenge strain and second vaccine: 1, 2, 3
- collection serum and commercial vaccine: 1, 2
- collection serum and influenza virus: 1
- collection serum and second vaccine: 1
- commercial vaccine and HI test: 1
- commercial vaccine and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- commercial vaccine and licensed commercial vaccine: 1, 2, 3, 4, 5
- commercial vaccine and second vaccine: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date